Ann: NYR Advances Xolatryp Phase IIa Trial in Cardioprotection, page-39

  1. 256 Posts.
    lightbulb Created with Sketch. 48
    Read the announcement! Focusing on the heart provides a potential entry space, which at this point is clinically unmet. Why ask others, on here, when you should just read and ascertain the information from the source? Management being smart imo.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
30.0¢
Change
0.000(0.00%)
Mkt cap ! $63.43M
Open High Low Value Volume
30.0¢ 30.0¢ 29.0¢ $245.6K 829.7K

Buyers (Bids)

No. Vol. Price($)
2 29101 29.5¢
 

Sellers (Offers)

Price($) Vol. No.
30.0¢ 311729 2
View Market Depth
Last trade - 16.10pm 08/08/2025 (20 minute delay) ?
NYR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.